abstract |
The invention relates to compounds of 2,3-dihydroimidazo [1,2-c] quinazoline for the formulations of pharmaceutical compositions containing such compounds, the use of these compounds or compositions for inhibiting phosphatidyl inositol-3-kinase (PI3K) and the treatment of diseases associated with the activity of phosphotidyl inositol-3- kinases (PI3K), with specific treatment of hyperproliferative disorders and / or angiogenesis disorders, as a single agent or in combination with other active ingredients. |